Dr. Muhammed Majeed was born and raised in Kerala, India.
After graduating in Pharmacy from Kerala University, Majeed emigrated to USA in 1975. He continued his graduate studies in Long Island University, New York (M.S.) and St. John’s University New York (Ph.D.) specializing in Industrial Pharmacy.
Dr. Majeed has over 15 years of research experience in progressively responsible research positions with Pfizer Inc., Carter-Wallace and Paco Research.
Sabinsa Corporation, a research oriented pharmaceutical and nutraceutical marketing company, was founded by Dr. Majeed in 1988. Although the transition from a researcher to a marketing company was a tremendous challenge, Dr. Majeed handled it successfully. At present, this New Jersey based firm employs over 60 people.
In 1991, Dr. Majeed set up a research group at Bangalore, India called Sami Labs Ltd. The facility now has over 500 people working for the company. Sami Labs combines manufacturing and global marketing of nutraceuticals and fine chemicals with cutting edge research.
SAMI’s research based new products picked up recognition from the Indian Government as well. Sami received the National award for quality products from the PRESIDENT OF INDIA in the area of Basic Drugs . Both QUALITY and INNOVATION were the key components that resulted in the award. In addition, Sami pioneered the research and marketing of a number of phytonutrients based on Indian raw materials. Sami Labs was also honored twice by the Spices Board of India, receiving one award for developing a market for Garcinia cambogia and the other for export performance.
Dr. Majeed received awards from several Indian American groups for his enterprising work and progress. He also received the 1996 Entrepreneur of the year award by the National Federation of Asian Americans.
In 1997, Sabinsa Corporation had been ranked America’s 90th fastest growing company by INC. Magazine. Sabinsa also ranked 7th in New Jersey among the fastest growing Technology based companies (New Jersey Fast 50).
In early 1999, Sami Labs started a division called Sami Spices based at Cochin, India to promote procurement and marketing of spices.
V.G Nair(VG) was the Managing Director of Karnataka Chemsyn Limited for over a decade and half. He has considerable experience in the API and Formulation areas. Prior to joining Chemsyn, he was Vice President, Life Science Division of the UB Group.
VG has also occupied senior positions overseas such as Manager – International Division of Emirates National Bank Limited and Chief Executive Officer of Emirates National Holdings, Dubai, prior to returning to India to join the UB group.
Shaheen Majeed knows Sabinsa from the ground up. When he was just 17 years old Shaheen began in the warehouse of the company his father founded in 1988, followed by a stint in customer service. He then handled a variety of sales positions, which included Tri-State region sales, California Sales Manager, and Latin American Business Development, a responsibility he still handles in addition to his role as Marketing Director.
Shaheen has also managed Contract Manufacturing, been Cosmetic Marketing Manager and Executive Assistant to the CEO. He is also spearheading the company’s expansion of their functional foods offerings.
In his spare time Shaheen earned a BA in Economics from Rutgers University, NJ and an MBA in Business Management from Keller Management School, CA. Additional Certificates from Executive MBA courses & schools attended includes:
In February 2009 Natural Foods Merchandiser magazine names him one of 40 under 40 notable members of the industry. In March 2009 Shaheen was elected to the Board of Trustees of the American Herbal Products Association.
Ms. Anju Majeed – daughter of Dr. Muhammed Majeed, Founder & Chairman, Sami-Sabinsa Group – is Director & Sr. Scientist at Sami Labs at Sami Labs. She finished her Master of Arts in Biology from Johns Hopkins University, Baltimore. And is currently pursuing her Ph.D. in microbiology. She has also gained an expertise in SAS and clinical SAS database management. Her passion comes from perseverance, urgency and a strong desire to contribute to the society. She puts this passion to work in everything she do and demonstrate courage to fight for ideas and objectives to raise the quality of the solutions.
A highly motivated person, drives new technologies and processes, develops new product formulations and scalable manufacturing processes for Sami which is further used in clinical trials through all phases of development. She works closely with analytical and formulation scientists and operates via multi-functional, global teams including API manufacturing, Process R&D, Pre-formulation and Pilot Plant Operations.
She is a true researcher with expertise in southern blotting, polymerase chain reaction (PCR), plasmid, RNA and DNA isolations, gel electrophoresis and other advance molecular biology techniques along with profound knowledge of sterile tissue culture techniques. She is primarily involved in planning and conducting experiments and analysing results, either with a definite end use, for example to develop new products, processes or commercial applications, or to broaden scientific understanding in general.
Her scientific understanding is also well proven by her numerous scientific publications and patents.